0 participants
64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2022-04-15
- Completion:
- 2022-05-16
Conditions
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
Interventions
- RADIATION
- BIOLOGICAL
- PROCEDURE
No Results Yet